New Delhi, September 3: The Department of Biotechnology (DBT) said on Friday that Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents.
Corbevax, an BD protein sub-unit vaccine, has been developed with supported from the Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council (BIRAC), it said.
|